WO1993000113A1 - A composition for treating a soft tissue injury - Google Patents
A composition for treating a soft tissue injury Download PDFInfo
- Publication number
- WO1993000113A1 WO1993000113A1 PCT/AU1992/000292 AU9200292W WO9300113A1 WO 1993000113 A1 WO1993000113 A1 WO 1993000113A1 AU 9200292 W AU9200292 W AU 9200292W WO 9300113 A1 WO9300113 A1 WO 9300113A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition according
- composition
- chemical
- ammonia
- soft tissue
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/02—Ammonia; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
Definitions
- a Composition for Treating a Soft Tissue Injury is particularly concerned with treatment of injured ligaments or other soft tissue injuries such as shin soreness of horses legs.
- injured ligaments or other soft tissue injuries such as shin soreness of horses legs.
- a race horse injures a leg whether this be by way of strained ligaments or other soft tissue injury, it is necessary to rest the race horse and hope that the injury will heal itself. In many cases, the injury will not heal itself and the race horse is prevented from racing again. It follows therefore, that there is a need for a composition for treatment of soft tissue leg injuries of horses which treatment ultimately leads to healing of the soft tissue injury.
- a composition for treating an injured ligament comprising a chemical for initiating swelling of soft tissue adjacent an injured region and an antiseptic which is arranged to pass through the swollen soft tissue to the injured region, the composition in use being arranged to draw affected material from the injured region through the surrounding soft tissue to promote healing of the injured region.
- the affected material is serum.
- the composition comprises a coagulant which is arranged to be carried through the swollen soft tissue to the injured region to reduce bleeding at the injured region.
- the composition increases blood flow in the injured region.
- the antiseptic preferably is carried by a carrier substance through the swollen soft tissue.
- the antiseptic is also a coagulant.
- the chemical for initiating swelling desirably acts to draw affected material from the injured region.
- the composition may be arranged to be applied to the soft tissue surrounding the injured region.
- the chemical is alkaline.
- the composition may comprise an oil.
- the oil may- act as a carrier for the antiseptic and coagulant and desirably act as a barrier to the chemical.
- the chemical increases blood flow to the injured region.
- the composition may permit exchange of gases through the soft tissue surrounding the injured region.
- composition increase blood flow to the injured region.
- the composition may increase movement of platelets to the injured region.
- the composition accelerates repair of cells in the injured region.
- the chemical may comprise ammonia in solution, preferably, NH4oH.
- the antiseptic comprises eucalyptus oil.
- the eucalyptus oil may comprise a carrier substance.
- the chemical preferably comprises cloudy ammonia.
- the chemical may comprise NH4oH and an alkaline substance.
- the chemical may comprise NH4oH and soap flakes or detergent.
- the chemical comprises soap flakes or an other alkaline substance in a proportion which makes up less than 5% of the composition by volume or by weight.
- the NH4oH may contain a binding agent or a surfactant such as soap flakes.
- the composition contains 3 to 85 millilitres of eucalyptus oil, 5 to 95 millilitres of cloudy ammonia and 0 to 40 millilitres of ammonia solution per 100 millilitres of composition.
- composition comprising 5 to 97% H4oH and 3 to 95% eucalyptus oil.
- the composition also contains 5 to 95% cloudy ammonia.
- the composition comprises an alkaline chemical such as NaoH.
- the alkaline • chemical is present in the composition in only a small amount less than 5% by volume of the overall composition.
- the composition comprises 0 to 95% by volume cloudy a ⁇ imonia.
- composition in accordance with the present invention can be made with the component shown in table 1.
- the overall concentration of ammonia is approximately 6.16% W/W H3 and in a 100ml solution eucalyptus oil comprises 11.54ml, cloudy ammonia 76.92ml and ammonia solution 11.54ml.
- the ingredients may be varied according to the information shown in table 2.
- the overall percentage of ammonia (assay NH3 W/W) can vary between 2% to 10%.
- the eucalyptus oil is poured into a glass bottle, then the cloudy ammonia solution is added and the bottle is sealed with an air tight seal and the bottle is then shaken until the contents are blended.
- the bottle is then allowed to sit out of direct sunlight in a cool spot for 3 to 6 weeks and the contents are blended by shaking twice a day for one week, then once a day until sufficiently blended or mixed and thus mature.
- the cloudy ammonia normally contains 30% NH3 and water and soap flakes.
- the cloudy ammonia acts to swell soft tissue surrounding an injured region and also acts as a carrier for the eucalyptus oil.
- the eucalyptus oil can be bought off the shelf and is produced by companies such as Fauldings and Double D and is an antiseptic and also acts as a coagulant to stop bleeding in the region of the injury and as a soothing agent.
- the ammonia solution is added to provide the desired concentration of NH4oH in order to provide swelling of the soft tissue and to carry the eucalyptus oil to the injured region.
- Cloudy ammonia can normally be bought off a supermarket shelf and one brand is named Castle and is produced by Ajax Chemicals Pty Ltd.
- the cloudy ammonia normally contains NH4oH in 3.7% W/W.
- the solution described above can be applied to a horses leg injury in the following manner.
- the part of the leg which is injured is clipped to remove hair and the solution is applied by a sponge, roller, paint brush, spray or hand.
- the horse After the solution is applied to the leg, the horse must be tied up for approximately 20 to 30 minutes to prevent it interfering with the treated region of its leg.
- the composition in solution When the composition in solution is applied in the above manner, healing of the injured region is substantially increased and straightening of tendons or ligaments which would otherwise heal with a bow or kink along their length.
- the recovery period is dependent upon the type of injury but is increased substantially and the composition is very effective in removing affected material such as, serum from the injured region to the exterior of the soft tissue and in addition, allows the antiseptic coagulant to enter the injured region although it is applied to the external surface of the skin adjacent the injured region.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A composition for treating an injured ligament of a horse comprising a chemical such as NH4oH for initiating swelling of soft tissue adjacent an injured region and an antiseptic such as eucalyptus oil which is arranged to pass through the swollen soft tissue to the injured region. The composition when used, draws affected material from the injured region through the surrounding soft tissue to promote healing of the injured region.
Description
A Composition for Treating a Soft Tissue Injury The present invention is particularly concerned with treatment of injured ligaments or other soft tissue injuries such as shin soreness of horses legs. Typically, if a race horse injures a leg whether this be by way of strained ligaments or other soft tissue injury, it is necessary to rest the race horse and hope that the injury will heal itself. In many cases, the injury will not heal itself and the race horse is prevented from racing again. It follows therefore, that there is a need for a composition for treatment of soft tissue leg injuries of horses which treatment ultimately leads to healing of the soft tissue injury.
In accordance with the present invention there is provided a composition for treating an injured ligament, comprising a chemical for initiating swelling of soft tissue adjacent an injured region and an antiseptic which is arranged to pass through the swollen soft tissue to the injured region, the composition in use being arranged to draw affected material from the injured region through the surrounding soft tissue to promote healing of the injured region.
Preferably, the affected material is serum. Preferably, the composition comprises a coagulant which is arranged to be carried through the swollen soft tissue to the injured region to reduce bleeding at the injured region.
Preferably, the composition increases blood flow in the injured region. The antiseptic, preferably is carried by a carrier substance through the swollen soft tissue.
It is further preferred that the antiseptic is also a coagulant. The chemical for initiating swelling, desirably acts to draw affected material from the injured region. The composition may be arranged to be applied to the soft tissue surrounding the injured region.
According to one embodiment of the present invention, the chemical is alkaline.
The composition may comprise an oil. The oil may- act as a carrier for the antiseptic and coagulant and desirably act as a barrier to the chemical.
Preferably, the chemical increases blood flow to the injured region.
The composition may permit exchange of gases through the soft tissue surrounding the injured region.
It is preferred that the composition increase blood flow to the injured region. The composition may increase movement of platelets to the injured region.
Optionally, the composition accelerates repair of cells in the injured region.
According to a further embodiment of the present invention, the chemical may comprise ammonia in solution, preferably, NH4oH.
Desirably, the antiseptic comprises eucalyptus oil.
The eucalyptus oil may comprise a carrier substance.
The chemical, preferably comprises cloudy ammonia.
The chemical may comprise NH4oH and an alkaline substance. Alternatively, the chemical may comprise NH4oH and soap flakes or detergent.
According to another embodiment of the present invention, the chemical comprises soap flakes or an other alkaline substance in a proportion which makes up less than 5% of the composition by volume or by weight.
The NH4oH may contain a binding agent or a surfactant such as soap flakes.
It is preferred that the composition contains 3 to 85 millilitres of eucalyptus oil, 5 to 95 millilitres of cloudy ammonia and 0 to 40 millilitres of ammonia solution per 100 millilitres of composition.
According to another aspect of the present invention there is provided a composition comprising 5 to
97% H4oH and 3 to 95% eucalyptus oil.
Preferably, the composition also contains 5 to 95% cloudy ammonia.
Alternatively, the composition comprises an alkaline chemical such as NaoH.
Preferably, the alkaline • chemical is present in the composition in only a small amount less than 5% by volume of the overall composition.
Preferably, the composition comprises 0 to 95% by volume cloudy aπimonia.
Preferred embodiments of the present invention will now be described by way of example only.
In its most preferred form, the composition in accordance with the present invention can be made with the component shown in table 1.
Quantity Ingredients
150ml Eucalyptus Oil (Linament Quality)
1 litre Cloudy Ammonia (Assay-2.88% NH3 W/W)
150ml 28% Ammonia Solution (Assay-28%-30% NH3 W/W)
The overall concentration of ammonia, is approximately 6.16% W/W H3 and in a 100ml solution eucalyptus oil comprises 11.54ml, cloudy ammonia 76.92ml and ammonia solution 11.54ml.
The ingredients may be varied according to the information shown in table 2.
Variation Ingredient Variation Range (%) Range (mis)
3-85 Eucalyptus Oil 3-85
0-95 Cloudy Ammonia 0-95 0-40 Ammonia Solution 0-40
The overall percentage of ammonia (assay NH3 W/W) can vary between 2% to 10%.
A method of mixing the above ingredients will now be described.
The eucalyptus oil is poured into a glass bottle, then the cloudy ammonia solution is added and the bottle is sealed with an air tight seal and the bottle is then shaken until the contents are blended. The bottle is then allowed to sit out of direct sunlight in a cool spot for 3 to 6 weeks and the contents are blended by shaking twice a day for one week, then once a day until sufficiently blended or mixed and thus mature.
When the solution is ready for use, the strong ammonia solution is added and the bottle is once again shaken. The contents of the bottle are then ready for use. The cloudy ammonia normally contains 30% NH3 and water and soap flakes.
The ingredients described above can be • varied. Cloudy ammonia for instance, can be replaced by peanut oil or olive oil as long as the ammonia solution is still retained.
Considering each of the components of the composition individually, it is generally considered that the cloudy ammonia acts to swell soft tissue surrounding an injured region and also acts as a carrier for the eucalyptus oil. The eucalyptus oil can be bought off the shelf and is produced by companies such as Fauldings and Double D and is an antiseptic and also acts as a coagulant to stop bleeding in the region of the injury and as a soothing agent. The ammonia solution is added to provide the desired concentration of NH4oH in order to provide swelling of the soft tissue and to carry the eucalyptus oil to the injured region.
Cloudy ammonia can normally be bought off a supermarket shelf and one brand is named Castle and is produced by Ajax Chemicals Pty Ltd. The cloudy ammonia normally contains NH4oH in 3.7% W/W. The ammonia solution can also be brought from Ajax Chemicals Pty Ltd under the name Uni-Var Analytical Reagent. In this form,
the ammonia solution is 28% NH4oH = 35.05, NH3 = 17.03. The NH3 is 28% to 30% W/W, 250 to 265 g/1.
The solution described above can be applied to a horses leg injury in the following manner. The part of the leg which is injured is clipped to remove hair and the solution is applied by a sponge, roller, paint brush, spray or hand. After the solution is applied to the leg, the horse must be tied up for approximately 20 to 30 minutes to prevent it interfering with the treated region of its leg.
When the composition in solution is applied in the above manner, healing of the injured region is substantially increased and straightening of tendons or ligaments which would otherwise heal with a bow or kink along their length. The recovery period is dependent upon the type of injury but is increased substantially and the composition is very effective in removing affected material such as, serum from the injured region to the exterior of the soft tissue and in addition, allows the antiseptic coagulant to enter the injured region although it is applied to the external surface of the skin adjacent the injured region.
Claims
1. A composition for treating an injured ligament, comprising a chemical for initiating swelling of soft tissue adjacent an injured region and an antiseptic which is arranged to pass through the swollen soft tissue to the injured region, the composition in use being arranged to draw affected material from the injured region through the surrounding soft tissue to promote healing of the injured region.
2. A composition according to claim 1 further comprising a coagulant which is arranged to be carried through the swollen soft tissue to the injured region to reduce bleeding at the injured region.
3. A composition according to claim 1 or 2 which in use, increases blood flow in the injured region.
4. A composition as claimed in any one of the preceding claims further comprising a carrier substance for carrying the antiseptic through the swollen soft tissue.
5. A composition according to any one of the preceding claims wherein the antiseptic is a coagulant.
6. A composition according to any one of the preceding claims wherein the chemical for initiating swelling acts to draw effected material from the injured region.
7. A composition according to any one of the preceding claims wherein the chemical is alkaline.
8. A composition according to any one of the preceding claims wherein the composition comprises an oil.
9. A composition according to claim 8 wherein the oil acts as a carrier for the antiseptic and as a coagulant.
10. A composition according to claim 9 wherein the oil acts as a barrier to the chemical.
11. A composition according to any one of the preceding claims wherein the chemical increases blood flow to the injured region.
12. A composition according to any one of the preceding claims comprising a component which permits exchange of gases through the soft tissue surrounding the injured region.
13. A composition according to any one of the preceding claims wherein the chemical comprises ammonia in solution.
14. A composition according to claim 13 wherein the chemical is NH4oH.
15. A composition according to any one of the preceding claims wherein the antiseptic comprises eucalyptus oil.
16. A composition according to claim 15 wherein the eucalyptus oil comprises a carrier substance.
17. A composition according to any one of the preceding claims wherein the chemical comprises cloudy ammonia.
18. A composition according to any one of the preceding claims wherein the chemical comprises an alkaline substance in addition to NH4oH.
19. A composition according to claim 18 wherein the alkaline substance comprises soap flakes or detergent.
20. A composition according to claim 20 wherein the chemical comprises soap flakes or another alkaline substance in a proportion which makes up less than 5% of the composition by volume or by weight.
21. A composition according to claim 20 wherein the NH4oH contains a binding agent or a surfactant.
22. A composition according to claim 1 comprising 3 to 85 millilitres of eucalyptus oil, 5 to 95 millilitres of cloudy ammonia and 0 to 40 millilitres of ammonia solution per 100 millilitres of composition.
23. A composition for treating an injured ligament, comprising 5 to 97% NH4oH and 3 to 95% eucalyptus oil.
24. A composition according to claim 23 further comprising 5 to 95% cloudy ammonia.
25. A composition according to claim 23 and 24 wherein the composition comprises 5 to 97% by volume NH4oH, 3 to 95% by volume eucalyptus oil and 0 to 95% by volume cloudy ammonia.
26. A composition according to claim 23 wherein a 1.3 litre sample of the composition comprises 150 millilitres eucalyptus oil of linament quality, 1 litre of cloudy ammonia of Assay-2.88% NH3 W/W and 150 millilitres of 28% ammonia solution of Assay-28%-30% NH3 W/W.
27. A composition substantially as hereinbefore described with reference to table 1 or table 2.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPK6842 | 1991-06-21 | ||
AUPK684291 | 1991-06-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993000113A1 true WO1993000113A1 (en) | 1993-01-07 |
Family
ID=3775490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/AU1992/000292 WO1993000113A1 (en) | 1991-06-21 | 1992-06-17 | A composition for treating a soft tissue injury |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1993000113A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003004038A1 (en) * | 2001-07-03 | 2003-01-16 | Mendez Pando Hector | Topically-applied composition based on ammonium hydroxide |
CN104173855A (en) * | 2014-08-07 | 2014-12-03 | 山东中医药大学 | External heat-clearing swelling-diminishing traditional Chinese medicine composition and using method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU506646A (en) * | 1946-07-12 | 1947-06-12 | Improvements in and relating to soaps and medicinal compositions | |
DE2353386A1 (en) * | 1973-10-25 | 1975-05-07 | Helmut Mueller | Rheumatism and lumbago treatment compsn. - contg. formic acid, camphor, ammonia, turpentine, templin oil, anisol, ether, olive oil and soap |
DE2639346A1 (en) * | 1975-09-03 | 1977-03-17 | Kenneth Martin Grout | Compsns. for treating insect bites and stings - contg. ammonia and antiseptic |
US4172888A (en) * | 1978-09-12 | 1979-10-30 | Robert E. Delzell, Sr. | Athlete's foot treatment |
EP0321870A1 (en) * | 1987-12-21 | 1989-06-28 | Theratech, Inc. | Skin penetration enhancement using free base and acid addition salt combinations of active agents |
EP0343671A2 (en) * | 1988-05-27 | 1989-11-29 | Dai-Ichi Kogyo Seiyaku Co., Ltd. | Pharmaceutical composition for the treatment of skin wounds |
-
1992
- 1992-06-17 WO PCT/AU1992/000292 patent/WO1993000113A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU506646A (en) * | 1946-07-12 | 1947-06-12 | Improvements in and relating to soaps and medicinal compositions | |
DE2353386A1 (en) * | 1973-10-25 | 1975-05-07 | Helmut Mueller | Rheumatism and lumbago treatment compsn. - contg. formic acid, camphor, ammonia, turpentine, templin oil, anisol, ether, olive oil and soap |
DE2639346A1 (en) * | 1975-09-03 | 1977-03-17 | Kenneth Martin Grout | Compsns. for treating insect bites and stings - contg. ammonia and antiseptic |
US4172888A (en) * | 1978-09-12 | 1979-10-30 | Robert E. Delzell, Sr. | Athlete's foot treatment |
EP0321870A1 (en) * | 1987-12-21 | 1989-06-28 | Theratech, Inc. | Skin penetration enhancement using free base and acid addition salt combinations of active agents |
EP0343671A2 (en) * | 1988-05-27 | 1989-11-29 | Dai-Ichi Kogyo Seiyaku Co., Ltd. | Pharmaceutical composition for the treatment of skin wounds |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003004038A1 (en) * | 2001-07-03 | 2003-01-16 | Mendez Pando Hector | Topically-applied composition based on ammonium hydroxide |
CN104173855A (en) * | 2014-08-07 | 2014-12-03 | 山东中医药大学 | External heat-clearing swelling-diminishing traditional Chinese medicine composition and using method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3892845A (en) | Hair shade adjuster | |
RU2004108049A (en) | COMPOSITION FOR HANDLING HAIR AND METHOD FOR PREPARING IT | |
KR870007324A (en) | A method of dyeing keratin fibers with 5,6-dihydroxyindole bound with an oxide and a dyeing composition for use. | |
DE3775116D1 (en) | METHOD FOR NEUTRALIZING UNPLEASANT ODORS OF ANIMAL EXCREMENT. | |
DE60107252D1 (en) | ANTIMICROBIAL COMPOSITION FOR TREATING BOVINE MASTITIS | |
ATE228765T1 (en) | COMPOSITION AND METHOD FOR TREATING PLANTS WITH EXOGENOUS CHEMICALS | |
CA2034746C (en) | Method of neutralizing hazardous products and composition therefor | |
WO1993000113A1 (en) | A composition for treating a soft tissue injury | |
ATE226058T1 (en) | USE OF LYSINE TO TREAT HAIR LOSS | |
SE9300105D0 (en) | STABLE PROTEIN SOLUTION | |
AU2163392A (en) | A composition for treating a soft tissue injury | |
US5645823A (en) | Keratinous tissue conditioner | |
EP0180067A1 (en) | Deodorant compositions containing persimmon juice as active ingredient | |
BR9406905A (en) | Composition for deodorizing animal waste and corresponding deodorizing process | |
BG102416A (en) | Composition containing at least sodium hydrogencarbonate, and a method for its preparation and application | |
US5147634A (en) | Heat generating permanent waving composition | |
JPS6050460B2 (en) | deodorizer | |
US3331743A (en) | Cyclohexylcyclohexanone in mercaptoacetate hair-treating compositions | |
EA199700032A1 (en) | DISINFECTING COMPOSITION "VELTOLEN" | |
SE9801705D0 (en) | Biologically active composition | |
GB2405586A (en) | Headlice treatment composition | |
JPS63203608A (en) | Hair removing agent | |
WO1997005885A1 (en) | Method of obtaining a molecular soluble keratin 'keratan' | |
JPH01293873A (en) | Deodorizing aromatic for shoes | |
US20190365636A1 (en) | Natural and Organic Deodorant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AT AU BB BG BR CA CH CS DE DK ES FI GB HU JP KP KR LK LU MG MN MW NL NO PL RO RU SD SE US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE BF BJ CF CG CI CM GA GN ML MR SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |